A recent multicenter study in Iran assessed breast cancer care quality indicators, revealing significant disparities from European standards.
The research, analyzing data from over 6,000 patients, highlighted challenges in healthcare systems of low- and middle-income countries in managing breast cancer.
Breast cancer, a major global health concern, varies in care quality across different income settings despite diagnostic and therapeutic advancements.
Iran, experiencing a rising breast cancer incidence, lacked prior exploration of adherence to European Society of Breast Cancer Specialists quality standards.
The study conducted by Rajabpour et al. evaluated 21 care quality indicators using a nationwide Clinical Breast Cancer Registry.
Findings exposed shortcomings in Iran's breast cancer care system, with 15 out of 21 indicators falling below EUSOMA's minimum standards.
Recommendations include policy reforms, healthcare infrastructure reinforcement, and international best practice integration for standardized care.
The study underlines systemic healthcare challenges in low- and middle-income countries and advocates for collaborative initiatives for capacity building.
Data analysis challenges in resource-constrained settings underscore the need for robust cancer registries to enhance monitoring and quality assurance.
While EUSOMA guidelines provide a valuable framework, adaptation to local realities is crucial for effective implementation in diverse healthcare contexts.